Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7

Circulation

Volumn 127, Issue 4, 2013, Pages 463-475

  Vergani, Andrea ^a,b   Tezza, Sara ^a   D'Addio, Francesca ^a,b   Fotino, Carmen ^c   Liu, Kaifeng ^d   Niewczas, Monika ^e,f   Bassi, Roberto ^a,b   Molano, R Damaris ^c   Kleffel, Sonja ^a   Petrelli, Alessandra ^b   Soleti, Antonio ^g   Ammirati, Enrico ^a,b,g   Frigerio, Maria ^g   Visner, Gary ^a   Grassi, Fabio ^h   Ferrero, Maria E ⁱ   Corradi, Domenico ^j   Abdi, Reza ^a   Ricordi, Camillo ^c   Sayegh, Mohamed H ^a   Pileggi, Antonello ^b,c   Fiorina, Paolo ^a,b   more..

^a Medical School   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MIAMI   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f Medestea Research   (Italy)

^g OSPEDALE NIGUARDA CA GRANDA   (Italy)

^h INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j UNIVERSITY OF PARMA   (Italy)

more..

Author keywords

Immunology; P2X7R; Rejection; Transplantation

Indexed keywords

PURINERGIC P2X7 RECEPTOR; STAT3 PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CARDIAC GRAFT REJECTION; FEMALE; GRAFT SURVIVAL; HEART GRAFT; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH17 CELL; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ADULT; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPETENCE; ISOANTIGENS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X7; STAT3 TRANSCRIPTION FACTOR; SURVIVORS; TH1 CELLS; TH17 CELLS;

EID: 84873145622     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.123653     Document Type: Article

References (41)

1. Shah MR, Starling RC, Schwartz Longacre L, Mehra MR; Working Group Participants. Heart transplantation research in the next decade-a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working Group. J Am Coll Cardiol. 2012;59:1263-1269.
2. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, Dobbels F, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant. 2010;29:1089-1103.
3. Hunt SA, Haddad F. The changing face of heart transplantation. J Am Coll Cardiol. 2008;52:587-598.
4. Arora S, Gude E, Sigurdardottir V, Mortensen SA, Eiskjær H, Riise G, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Aukrust P, Solbu D, Iversen M, Gullestad L. Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate. J Heart Lung Transplant. 2012;31:259-265.
5. Sayegh MH, Carpenter CB. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med. 2004;351:2761-2766. (Pubitemid 39665333)
6. Murphy SP, Porrett PM, Turka LA. Innate immunity in transplant tolerance and rejection. Immunol Rev. 2011;241:39-48.
7. Rothstein DM, Sayegh MH. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev. 2003;196:85-108. (Pubitemid 37468106)
8. Bour-Jordan H, Esensten JH, Martinez-Llordella M, Penaranda C, Stumpf M, Bluestone JA. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol Rev. 2011;241:180-205.
9. Ariyan C, Salvalaggio P, Fecteau S, Deng S, Rogozinski L, Mandelbrot D, Sharpe A, Sayegh MH, Basadonna GP, Rothstein DM. Cutting edge: transplantation tolerance through enhanced CTLA-4 expression. J Immunol. 2003;171:5673-5677. (Pubitemid 37467180)
10. King CL, Devitt JJ, Lee TD, Hancock Friesen CL. Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy. J Cardiothorac Surg. 2010;5:52.
11. Shen X, Reng F, Gao F, Uchida Y, Busuttil RW, Kupiec-Weglinski JW, Zhai Y. Alloimmune activation enhances innate tissue inflammation/injury in a mouse model of liver ischemia/reperfusion injury. Am J Transplant. 2010;10:1729-1737.
12. Novak I. ATP as a signaling molecule: the exocrine focus. News Physiol Sci. 2003;18:12-17. (Pubitemid 36299377)
13. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N, Ravichandran KS. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature. 2009;461:282-286.
14. Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, Fumagalli M, Verderio C, Buer J, Scanziani E, Grassi F. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal. 2008;1:ra6.
15. Piccini A, Carta S, Tassi S, Lasiglié D, Fossati G, Rubartelli A. AT P is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA. 2008;105:8067-8072. (Pubitemid 351904709)
16. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413-492. (Pubitemid 28477681)
17. Khakh BS, North RA. P2X receptors as cell-surface ATP sensors in health and disease. Nature. 2006;442:527-532. (Pubitemid 44167906)
18. Wilhelm K, Ganesan J, Müller T, Dürr C, Grimm M, Beilhack A, Krempl CD, Sorichter S, Gerlach UV, Jüttner E, Zerweck A, Gärtner F, Pellegatti P, Di Virgilio F, Ferrari D, Kambham N, Fisch P, Finke J, Idzko M, Zeiser R. Graft-versus-host disease is enhanced by extracellular AT P activating P2X7R. Nat Med. 2010;16:1434-1438.
19. Junger WG. Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol. 2011;11:201-212.
20. Casati A, Frascoli M, Traggiai E, Proietti M, Schenk U, Grassi F. Cellautonomous regulation of hematopoietic stem cell cycling activity by ATP. Cell Death Differ. 2011;18:396-404.
21. Woehrle T, Yip L, Elkhal A, Sumi Y, Chen Y, Yao Y, Insel PA, Junger WG. Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. Blood. 2010;116:3475-3484.
22. Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, Onoue M, Yagita H, Ishii N, Evans R, Honda K, Takeda K. ATP drives lamina propria T (H) 17 cell differentiation. Nature. 2008;455:808-812.
23. Schenk U, Frascoli M, Proietti M, Geffers R, Traggiai E, Buer J, Ricordi C, Westendorf AM, Grassi F. ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci Signal. 2011;4:ra12.
24. Chadha R, Heidt S, Jones ND, Wood KJ. Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance? Transplantation. 2011;91:939-945.
25. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, D'Addio F, Mfarrej B, Donnarumma M, Habicht A, Clarkson MR, Iacomini J, Glimcher LH, Sayegh MH, Ansari MJ. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med. 2008;205:3133-3144.
26. Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol. 2011;187:676-683.
27. Placido R, Auricchio G, Falzoni S, Battistini L, Colizzi V, Brunetti E, Di Virgilio F, Mancino G. P2X (7) purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability. Cell Immunol. 2006;244:10-18. (Pubitemid 46671397)
28. Murgia M, Hanau S, Pizzo P, Rippa M, Di Virgilio F. Oxidized A T P. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J Biol Chem. 1993;268:8199-8203. (Pubitemid 23120407)
29. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, Andersen CB, Angelini A, Berry GJ, Burke MM, Demetris AJ, Hammond E, Itescu S, Marboe CC, McManus B, Reed EF, Reinsmoen NL, Rodriguez ER, Rose AG, Rose M, Suciu-Focia N, Zeevi A, Billingham ME. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710-1720. (Pubitemid 41641841)
30. Bruschi G, Colombo T, Oliva F, Morici N, Botta L, Cannata A, Frigerio M, Martinelli L. Orthotopic heart transplantation with donors greater than or equal to 60 years of age: a single-center experience. Eur J Cardiothorac Surg. 2011;40:e55-e61.
31. Ueno T, Habicht A, Clarkson MR, Albin MJ, Yamaura K, Boenisch O, Popoola J, Wang Y, Yagita H, Akiba H, Ansari MJ, Yang J, Turka LA, Rothstein DM, Padera RF, Najafian N, Sayegh MH. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. J Clin Invest. 2008;118:742-751. (Pubitemid 351206562)
32. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation. 1973;16:343-350.
33. Vergani A, D'Addio F, Jurewicz M, Petrelli A, Watanabe T, Liu K, Law K, Schuetz C, Carvello M, Orsenigo E, Deng S, Rodig SJ, Ansari JM, Staudacher C, Abdi R, Williams J, Markmann J, Atkinson M, Sayegh MH, Fiorina P. A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice. Diabetes. 2010;59:2253-2264.
34. O'Shea JJ, Lahesmaa R, Vahedi G, Laurence A, Kanno Y. Genomic views of STAT function in CD4+ T helper cell differentiation. Nat Rev Immunol. 2011;11:239-250.
35. Dhillon NK, Peng F, Ransohoff RM, Buch S. PDGF synergistically enhances IFN-gamma-induced expression of CXCL10 in blood-derived macrophages: implications for HIV dementia. J Immunol. 2007;179:2722-2730.
36. Chiba T, Yamada M, Aiso S. Targeting the JAK2/STAT3 axis in Alzheimer's disease. Expert Opin Ther Targets. 2009;13:1155-1167.
37. Kariya S, Takahashi N, Hirano M, Ueno S. Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes. Mol Cell Biochem. 2003;254:83-89. (Pubitemid 37483742)
38. Arulkumaran N, Unwin RJ, Tam FW. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs. 2011;20:897-915.
39. Gulbransen BD, Bashashati M, Hirota SA, Gui X, Roberts JA, MacDonald JA, Muruve DA, McKay DM, Beck PL, Mawe GM, Thompson RJ, Sharkey KA. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat Med. 2012;18:600-604.
40. Egwuagu CE. STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine. 2009;47:149-156.
41. Siegel AM, Heimall J, Freeman AF, Hsu AP, Brittain E, Brenchley JM, Douek DC, Fahle GH, Cohen JI, Holland SM, Milner JD. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity. 2011;35:806-818.